Breast cancer bone metastases: pathogenesis and therapeutic targets

The International Journal of Biochemistry & Cell Biology
Naomi BrookArlene Chan

Abstract

Breast cancer is the most common cancer affecting women worldwide, with bone metastases presenting as the most common site of disease recurrence. Bone metastases secondary to breast cancer negatively impacts patient survival, mobility, and quality of life. Furthermore, the clinical complications of breast cancer bone metastases are associated with significant financial burden to the individual and society. The molecular mechanisms involved in the metastasis, colonisation, and proliferation of breast cancer cells in bone are complex and involve crosstalk between breast cancer cells and the bone microenvironment. The ability of metastatic breast cancer cells to hijack normal biological processes involved in bone remodelling is a key driver of osteolytic and osteoblastic bone lesions. As such, our understanding of how breast cancer cells manipulate normal bone remodelling pathways is essential for the development of new therapeutic agents to improve patient outcomes. In this review, we discuss bone remodelling under normal physiological conditions and explore key pathways dysregulated in breast cancer metastasis to bone. We provide an overview of systemic therapies currently recommended for the treatment of breast cancer bone meta...Continue Reading

Citations

Aug 22, 2018·Expert Opinion on Pharmacotherapy·Zeynep OruçÇağatay Arslan
Jul 23, 2019·Clinical and Experimental Pharmacology & Physiology·Gaetano Leto
Oct 6, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Luqi WangHiroki Yokota
May 8, 2020·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Kyung-Hun LeeSeock-Ah Im
Feb 6, 2020·The Journal of Gene Medicine·Chao ZhangHongchuan Jiang
Feb 9, 2020·International Journal of Molecular Sciences·Paola Maroni
Dec 20, 2018·BMC Cancer·Christopher N CultraraJenny Zilberberg
Jul 11, 2018·Diagnostics·Alessandro SteccoAlessandro Carriero
Jul 18, 2020·International Journal of Molecular Sciences·Eunah Shin, Ja Seung Koo
May 24, 2020·International Journal of Molecular Sciences·Simona TavernaVincenza Dolo
Nov 27, 2020·Cancers·Naomi BrookArun Dharmarajan
Feb 13, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Guillaume RieunierThomas Bogenrieder
Oct 31, 2020·Frontiers in Bioengineering and Biotechnology·Ania Naila GuerrieriEnrico Lucarelli
Mar 17, 2019·Pharmacology & Therapeutics·Asurayya WorredeAlessandro Fatatis
Mar 30, 2021·Frontiers in Bioengineering and Biotechnology·Indira SigdelYuan Tang
Apr 6, 2021·Frontiers in Cell and Developmental Biology·Xianyi MengAline Bozec
May 1, 2021·Journal of Clinical Medicine·Angelica PetrilloBruno Daniele
Apr 20, 2021·JBMR Plus·David B VaughtDana Brantley-Sieders
May 29, 2021·The International Journal of Neuroscience·Md SakibuzzamanTasnuva Tarannum Fariza
May 26, 2021·Molecular and Cellular Endocrinology·Melissa C McHannJosée Guindon
Jul 9, 2021·Critical Reviews in Oncology/hematology·M C SanmartinN A Chasseing
Aug 8, 2021·International Journal of Molecular Sciences·Luca AmbrosioVincenzo Denaro
May 13, 2019·ACS Biomaterials Science & Engineering·Elham HatamiMurali Mohan Yallapu
Aug 5, 2020·Clinical Oncology : a Journal of the Royal College of Radiologists·A ChallapalliA Bahl
Oct 13, 2021·Cellular and Molecular Life Sciences : CMLS·Zhiguo LingYueqi Chen
Nov 26, 2021·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Jingyao CuiXin Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.